WallStreetZenWallStreetZen

NASDAQ: MDXH
Mdxhealth Sa Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for MDXH

Based on 1 analyst offering 12 month price targets for Mdxhealth Sa.
Min Forecast
$6.00+76.99%
Avg Forecast
$6.00+76.99%
Max Forecast
$6.00+76.99%

Should I buy or sell MDXH stock?

Based on 1 analyst offering ratings for Mdxhealth Sa.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MDXH stock forecasts and price targets.

MDXH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-09

1 of 1

Forecast return on equity

Is MDXH forecast to generate an efficient return?
Company
-124.25%
Industry
9.64%
Market
39.07%
MDXH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MDXH forecast to generate an efficient return on assets?
Company
-16.33%
Industry
3.57%
MDXH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MDXH revenue forecast

What is MDXH's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$69.9M
Avg 2 year Forecast
$79.2M
Avg 3 year Forecast
$87.8M

MDXH vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
MDXH$3.39$6.00+76.99%Strong Buy
PRPO$6.50N/AN/A
XWEL$2.04$7.00+243.47%Buy
APDN$0.88$2.00+127.01%Buy
NDRA$1.50N/AN/A
View Top Diagnostic & Research Stocks

Mdxhealth Sa Stock Forecast FAQ

Is Mdxhealth Sa Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: MDXH) stock is to Strong Buy MDXH stock.

Out of 1 analyst, 1 (100%) are recommending MDXH as a Strong Buy, 0 (0%) are recommending MDXH as a Buy, 0 (0%) are recommending MDXH as a Hold, 0 (0%) are recommending MDXH as a Sell, and 0 (0%) are recommending MDXH as a Strong Sell.

If you're new to stock investing, here's how to buy Mdxhealth Sa stock.

What is MDXH's revenue growth forecast for 2023-2025?

(NASDAQ: MDXH) Mdxhealth Sa's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 0%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 6.64%.

Mdxhealth Sa's revenue in 2023 is N/A.On average, 2 Wall Street analysts forecast MDXH's revenue for 2023 to be $1,889,692,390, with the lowest MDXH revenue forecast at $1,886,718,199, and the highest MDXH revenue forecast at $1,892,666,580. On average, 2 Wall Street analysts forecast MDXH's revenue for 2024 to be $2,141,119,626, with the lowest MDXH revenue forecast at $2,135,684,969, and the highest MDXH revenue forecast at $2,146,554,283.

In 2025, MDXH is forecast to generate $2,373,674,272 in revenue, with the lowest revenue forecast at $2,373,674,272 and the highest revenue forecast at $2,373,674,272.

What is MDXH's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: MDXH) forecast ROA is -16.33%, which is lower than the forecast US Diagnostics & Research industry average of 3.57%.

What is MDXH's Price Target?

According to 1 Wall Street analyst that have issued a 1 year MDXH price target, the average MDXH price target is $6.00, with the highest MDXH stock price forecast at $6.00 and the lowest MDXH stock price forecast at $6.00.

The Wall Street analyst predicted that Mdxhealth Sa's share price could reach $6.00 by Nov 9, 2024. The average Mdxhealth Sa stock price prediction forecasts a potential upside of 76.99% from the current MDXH share price of $3.39.

What is MDXH's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: MDXH) forecast ROE is -124.25%, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.